Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
Nature

The future of at-home molecular testing

During the COVID-19 health emergency, two strategies for detecting coronavirus infections were commonly adopted around the world. Part of Nature Outlook: Medical diagnostics Initially, in countries ...
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Assembly Magazine

Micro-Scale Leak Testing of Medical Devices

Given the highly infectious nature of the COVID pathogen, tests for the virus had to be quick, reliable and safe. The test ...
Becker's Hospital Review

Closing the Rural Diagnostic Gap with Next-Morning PCR Tests for Infections

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...